Goldman Sachs Maintains Buy on Exact Sciences, Raises Price Target to $110
Portfolio Pulse from Benzinga Newsdesk
Goldman Sachs analyst Matthew Sykes has maintained a 'Buy' rating on Exact Sciences (NASDAQ:EXAS) and raised the price target from $85 to $110.
July 21, 2023 | 12:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Goldman Sachs has maintained a 'Buy' rating on Exact Sciences and raised the price target from $85 to $110.
The raised price target by Goldman Sachs indicates a positive outlook for Exact Sciences. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100